关节镜术后血栓预防:法国实践调查与推荐意见比较
本研究通过问卷调查法国关节镜学会(SFA)成员的关节镜术后血栓预防实践,并与法国麻醉与重症监护学会(SFAR)现行国家推荐进行比较。35%的SFA成员回复问卷,总体依从率为69%,显著低于75%的预设目标(p<0.001)。髋关节手术、膝关节小手术和踝关节手术的依从率显著低于目标,均表现为处方过度;膝关节大手术和上肢手术依从率与目标无显著差异。作者认为推荐意见与临床实践之间存在较大差距,应重新审视现行推荐及关节镜术后药物性血栓预防的成本效益比。
要点
- SFA成员关节镜术后血栓预防总体依从率为69%,显著低于75%的预设目标(p<0.001)。
- 髋关节手术、膝关节小手术和踝关节手术的预防性处方过度,依从率显著低于目标。
- 膝关节大手术和上肢手术的依从率与75%目标无显著差异。
- 不依从的唯一原因是无正当理由的处方(处方过度)。
- 作者认为近期研究不支持扩大预防性处方,应重新评估现行推荐及药物性血栓预防的成本效益比。
适用人群与场景
- 法国关节镜学会(SFA)成员,即开展关节镜手术的外科医生。
- 涉及关节镜手术类型:髋关节手术、膝关节大手术、膝关节小手术、踝关节手术、上肢手术。
研究设计与关键结果
- 研究类型:问卷调查(描述性统计),比较SFA成员临床实践与SFAR现行国家推荐。
- 回复率:35%的SFA成员回复问卷。
- 总体依从率69%,显著低于75%目标阈值(p<0.001)。
- 髋关节手术、膝关节小手术和踝关节手术的依从率显著低于目标,均为处方过度;膝关节大手术和上肢手术依从率与目标无显著差异。
- 不依从的唯一原因为无正当理由的处方。
证据类型、等级与局限
- 证据类型:问卷调查(描述性研究),证据等级Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 调查显示SFA成员关节镜术后血栓预防总体依从率69%,低于75%目标,下肢手术存在处方过度。
- 作者认为近期研究不支持扩大预防性处方,应重新考虑现行推荐的相关性并重新评估关节镜术后药物性血栓预防的成本效益比。
指南或共识出处
- 法国麻醉与重症监护学会(SFAR)关节镜术后血栓预防现行国家推荐(研究进行时有效)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Current national and international recommendations for thromboprophylaxis after arthroscopy procedures are not very detailed and likely not well known by surgeons. The aim of this study was to compare the daily clinical practices of members of the Francophone Arthroscopy Society (SFA) with current national and international recommendations.
HYPOTHESIS: The primary hypothesis was that the procedures adopted by more than 75% of SFA members conform to the national recommendations set out by the French Anesthesia and Intensive Care Society (SFAR) in effect at the time of this study.
METHODS: A questionnaire was sent to members of the SFA asking three questions to capture their protocol (decision maker, prescriber, indication by procedure). Descriptive statistics were generated for each question. The percentage of prescription protocols conforming to each recommendation was compared to the target percentage (75% arbitrary threshold) by a Chi2 test with a 5% threshold overall and for each type of procedure.
RESULTS: Thirty-five percent of the SFA members responded to the questionnaire. Overall, the compliance rate was 69%, which was significantly lower than the target (p<0.001). The compliance rate was significantly lower than the target for hip procedures, minor knee procedures and ankle procedures; each time, the prescription was excessive. The compliance rate was not different than the target for major knee procedures and upper limb procedures. The sole reason for non-compliance was a non-justified prescription.
DISCUSSION: Less than 75% of SFA members have adopted thromboprophylaxis protocols that comply with national SFAR recommendations in effect at the time of this study, with excessive prescription for procedures on the lower limb. Recent studies do not confirm that broadening of the prescription is justified. This large gap between published recommendations and current practices means that we should reconsider the relevance of current recommendations and re-evaluate the cost-benefit ratio of prescribing a drug-based thromboprophylaxis after arthroscopy surgery.
LEVEL OF EVIDENCE: Level IV.
参考来源
- Jenny JY. Thromboprophylaxis in arthroscopy: Survey of current practices in France and comparison with recommendations. Orthop Traumatol Surg Res. 2020. PMID: 32891547. doi:10.1016/j.otsr.2020.08.004
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。